On the evening of April 28, Shandong Bailong Chuangyuan Bio-Tech Co.Ltd(605016) released the first quarter report of 2022. During the reporting period, the company achieved an operating revenue of 198 million yuan, a year-on-year increase of 47.92%; The net profit attributable to the shareholders of the listed company was 407293 million yuan, a year-on-year increase of 133.38%; The net profit attributable to shareholders of listed companies after deducting non recurring profits and losses was 371914 million yuan, a year-on-year increase of 114.95%; Realize the basic earnings per share of 0.32 yuan / share.
The company said that the performance growth was mainly due to the growth of customer demand at home and abroad, the increase of product sales and the optimization and adjustment of product structure.
